Trump pledges to end the use of aborted baby tissues in federal research.
Joana Campos
The Trump administration is about to take a monumental step in defending life and scientific ethics by banning the use of fetal tissues from abortions in research funded by the National Institutes of Health (NIH).
This decision, driven by Trump’s nominee to lead the NIH, Jay Bhattacharya, and backed by key figures such as Senator Josh Hawley and Health and Human Services Secretary Robert F. Kennedy Jr., marks a milestone in the pro-life movement and the search for ethical alternatives in science.
During a hearing before the Senate Committee on Health, Education, Labor, and Pensions, Trump’s NIH nominee, Jay Bhattacharya, explicitly promised to ban the use of fetal tissues from abortions in research funded by the institution.
When Senator Josh Hawley asked him if he supported Kennedy’s intent to reinstate a policy from Trump’s first administration that severely restricted such research, Bhattacharya responded affirmatively, emphasizing that viable ethical alternatives exist.
@DrJBhattacharya promised that NO aborted fetal tissue will be used in NIH-funded research.
This statement not only reaffirms Trump’s commitment to pro-life values but also sends a clear message: science should not be based on the exploitation of innocent human lives.
The dark history of fetal tissue research.
The use of fetal tissues from abortions in scientific research has been a controversial practice for decades, funded by millions of taxpayer dollars.
During the Obama administration, for instance, approximately $115 million per year was allocated to such research, including macabre experiments like the creation of «humanized mice» through the transplantation of aborted baby tissues into rodents.
These horrifying practices not only raise serious ethical concerns but have also been questioned for their effectiveness, as many experts argue that they have not led to significant medical breakthroughs.
Trump’s first administration: An ethical precedent.
During his first term, Trump took significant steps to restrict these practices. In 2019, his administration implemented a policy that did not outright ban the use of fetal tissues but imposed strict restrictions, such as prohibiting the acquisition of new aborted fetal tissues for NIH-funded research and requiring ethical reviews by a dedicated committee.
Additionally, specific contracts were canceled, such as one with the University of California, San Francisco, which used fetal tissues from elective abortions for experiments involving «humanized mice.»
This policy was applauded by pro-life leaders but faced criticism from some scientists who defended the need for these tissues despite the existence of ethical alternatives.
Ethical alternatives: Science does not need barbarism.
A key argument in Bhattacharya’s proposal and the Trump administration’s policy is the availability of ethical alternatives for scientific research.
These include the use of pluripotent stem cells, tissues from placentas, umbilical cords, and amniotic fluid, as well as tissues from babies who died of natural causes, such as miscarriages.
In 2018, the Department of Health and Human Services (HHS) launched a $20 million initiative to fund the development of these alternatives, demonstrating that science can advance without compromising ethics.
Experts from the Charlotte Lozier Institute have pointed out that despite decades of research using aborted fetal tissues, no significant cures have been achieved, reinforcing the need for a change in direction.
The connection to Planned Parenthood: A moral scandal.
One particularly disturbing aspect of this practice is its link to Planned Parenthood, the largest abortion provider in the United States. Documents and reports have revealed that this organization has been involved in selling parts of aborted babies for research, profiting from what many consider a gruesome trade.
For example, investigative reports have exposed how Planned Parenthood provided fetal tissues to universities such as the University of Pittsburgh, where grotesque experiments were conducted, including grafting scalps from aborted babies onto mice.
The Trump administration has expressed its intent to cut federal funding to Planned Parenthood, which could further limit access to these tissues and dismantle this network of exploitation.
Transparency and accountability: A pending challenge.
A persistent issue in this field has been the lack of transparency regarding how fetal tissues are obtained and used. Investigative reports and congressional letters have denounced the opacity of institutions such as the University of Pittsburgh, where questionable experiments have been conducted using tissues from babies aborted in late pregnancy stages.
This lack of clarity has led to proposals for federal regulatory reforms, including requiring detailed certifications from institutions receiving funds and congressional hearings to thoroughly investigate these practices.
The Trump administration’s decision to ban the use of fetal tissues in NIH research forces us to reflect on the limits of science and ethics. Is it acceptable to sacrifice innocent human lives in the name of scientific progress, especially when viable alternatives exist?
Now more than ever, it is crucial that conservative and pro-life voices continue to rise in defense of the dignity of every human life, from conception to natural death.
About The Author
Subscribe to Our Newsletter